Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
Developing broadly applicable neoantigen-directed adoptive cell therapies (ACTs) is challenging because each cancer patient has an unique neoantigen repertoire. Here, the authors present the crystal structures of tumor-specific T cell receptors (TCRs) that recognize a shared neoepitope arising from...
Main Authors: | Daichao Wu, D. Travis Gallagher, Ragul Gowthaman, Brian G. Pierce, Roy A. Mariuzza |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-16755-y |
Similar Items
-
629 Targeting a shared TP53 neoantigen with bispecific T cell retargeting antibody
by: Nickolas Papadopoulos, et al.
Published: (2020-11-01) -
Structural basis for recognition of cellular and viral ligands by NK cell receptors
by: Roy eMariuzza, et al.
Published: (2014-03-01) -
The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies
by: Chang Yang, et al.
Published: (2021-06-01) -
Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG
by: David Zeman, et al.
Published: (2015-03-01) -
"AN ESTIMATION OF OLIGOCLONAL BANDS IN PATIENTS WITH MULTIPLE SCLEROSIS"
by: M. H. Harirchian, et al.
Published: (2004-09-01)